
Merck has announced that it has invested €35m in biosafety testing at its sites in Glasgow and Stirling, both Scotland. …

BATM have announced that it has developed a new method for the rapid and comprehensive diagnosis of tuberculosis (TB), which …

Most people who test positive for COVID-19 do not have symptoms of the virus when tested, according to the Office …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

